Latest Cadence Stories

SAN DIEGO, Calif., Dec. 12, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that it has entered into an agreement to terminate its exclusive option to acquire privately-held Incline Therapeutics, Inc., or Incline. Under the waiver, consent and option termination agreement signed by Cadence...

SAN DIEGO, Nov. 28, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) today announced that it has entered into settlement and license agreements with Perrigo Company (Nasdaq: PRGO; TASE), and its subsidiary, Paddock Laboratories, LLC, to resolve pending patent litigation involving OFIRMEV® (acetaminophen) injection. The settlement agreement includes a stipulation by the parties requesting dismissal with prejudice of the lawsuit filed by Cadence in the U.S. District...

STAUNTON, Va., Nov. 27, 2012 /PRNewswire/ -- Cadence, Inc., a leading provider of medical device outsourcing solutions, announced today that it will open a finished medical device facility in Cranberry Township, PA in the first quarter of 2013. The 21,000 square foot facility will include up to 10,000 square feet of clean room space and 5,000 square feet of office space. The company expects to employ as many as 60 people in the new facility located just outside of Pittsburgh....

STAUNTON, Va., Oct. 23, 2012 /PRNewswire/ -- Cadence, Inc., a leading provider of medical device outsourcing solutions, announced today that Alan Connor has been selected as the company's next Chief Executive Officer. Connor has been serving as the President since April 2011 and will succeed Peter Harris in April 2013 following a six month transition period. Harris will continue as Chairman of the Board. Prior to joining Cadence in 2011, Connor enjoyed a distinguished career in...

Firm shares new solutions in records and information management September 23-25, 2012. Atlanta, GA (PRWEB) September 18, 2012 Cadence Group will be showcasing their thought leadership at ARMA International’s 57th Annual Conference and Expo on September 23-25, 2012. As an exhibitor and participant at this year’s show, they will join thousands of Records and Information Management specialists in at the McCormick Center Chicago, IL. The conference will include two days of workshops,...

SAN DIEGO, May 2, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Chief Commercial Officer Scott Byrd will present the company's corporate overview on Tuesday, May 8, 2012 at 4:50pm Eastern Time (1:50pm Pacific Time) during the Deutsche Bank Securities, Inc. 37th Annual...

SUNNYVALE, Calif., March 14, 2012 /PRNewswire/ -- Vivante Corporation, a worldwide leader in graphics and visualization technologies for handheld and consumer devices, today announced that it has worked with Cadence (NASDAQ: CDNS) to qualify the Cadence double data rate (DDR) Memory controller on-chip intellectual property (IP) solution for use with Vivante's graphics processing unit (GPU) IP solution. Vivante's high-performance multi-core GPUs are capable of processing massive...

SAN DIEGO, March 12, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today reported financial results for the fourth quarter and year ended December 31, 2011. Highlights for the year ended December 31, 2011, and the fourth quarter of 2011, included the following: The launch of OFIRMEV® (acetaminophen) injection,...

VANCOUVER, British Columbia, Nov. 16, 2011 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: BioFuel (NASDAQ:BIOF), Cadence (NASDAQ:CADX), Chinacast Education (NASDAQ:CAST), Tellabs (NASDAQ:TLAB), Augme (OTC:AUGT) & Allezoe (OTC:ALZM). (Logo: http://photos.prnewswire.com/prnh/20110914/HK68141LOGO ) Investing in penny stocks is very risky given the high price volatility and lack of transparency...

SAN DIEGO, Oct. 27, 2011 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, today announced that it will release its third quarter ended September 30, 2011 financial results on Thursday, November 3, 2011. Cadence management will host a conference call and live webcast to discuss the financial results on Thursday, November 3, 2011...